Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001215:Asparaginase / Q000032:analysis / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D001216:Asparagine / Q000097:blood; D004926:Escherichia coli; D007700:Kinetics; D008099:Liver / Q000201:enzymology; D008223:Lymphoma / Q000188:drug therapy*; D008657:Metabolic Clearance Rate; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D012377:Rodentia; D013154:Spleen / Q000201:enzymology
D000970:Antineoplastic Agents; D001216:Asparagine; D001215:Asparaginase